SAN RAMON, Calif., January 19, 2021—In response to the growing adoption of its specialty contact lenses by eye care professionals, CooperVision Specialty EyeCare today announced investments in its Gilbert, Ariz., and Sherbrooke, Quebec manufacturing facilities.
The Gilbert site—in suburban Phoenix—currently produces Paragon CRT® contact lenses and materials. The company‘s ambitious expansion plans will grow the facility to more than 45,000 square feet by 2025, with a refurbished shipping and warehouse center, and a substantially larger specialty lens manufacturing floor.
The Sherbrooke facility—located southeast of Montreal—mainly produces Blanchard Onefit and Onefit MED scleral contact lenses. Accommodating increased volume demands from the Americas and other global markets, the site will benefit from several upgrades such as expanded advanced lathing technologies and renovated laboratory space.
Additionally, the company is undertaking a refurbishment and production expansion of our facility in the Netherlands to meet the growing demand in Europe and China for their range of lenses.
“Extending our partnerships with the eye care community also insists that we regularly invest in our infrastructure, especially given upward demand,” said Juan Carlos Aragón, President, Specialty Eye Care, CooperVision. “We look forward to providing our employees and customers with the many benefits afforded by these improvements.”
CooperVision Specialty EyeCare develops, manufacturers, and provides access to a portfolio of industry leading soft custom and rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea management and presbyopia management. Its steady voice, ongoing research and innovative products and services play a leading role in expanding care worldwide. The group’s brands include Blanchard, GP Specialists, Paragon, Procornea and Soflex.
# # #
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Maggie Munley, Associate Counselor, McDougall Communications
email@example.com or +1-585-434-2149